AMYRIS TO HOST THIRD QUARTER 2022 FINANCIAL RESULTS CONFERENCE CALL ON NOVEMBER 8

Rhea-AI Summary

Amyris, Inc. (Nasdaq: AMRS), a synthetic biotechnology company, will report its financial results for Q3 2022 on November 8, 2022, after market close. A conference call will follow at 1:30 PM PT, featuring CEO John Melo and CFO Han Kieftenbeld, discussing results and business updates. Amyris focuses on sustainable ingredients for Clean Health & Beauty and Flavors & Fragrances, leveraging its Lab-to-Market technology platform, which integrates machine learning and AI for rapid innovation, reaching over 300 million consumers through more than 20,000 products from top brands.

EMERYVILLE, Calif., Nov. 1, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market^TM technology platform and clean beauty consumer brands, today announced that it will issue its financial results for the third quarter ended September 30, 2022, on the afternoon of Tuesday, November 8, 2022, after closing of the financial markets.

The company will hold a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time), during which, John Melo, President and Chief Executive Officer, and Han Kieftenbeld, Chief Financial Officer, will discuss Amyris' financial results and provide an update on the company's business. Participants may access the live webcast on Amyris' Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing (844) 850-0551 (domestic) or (412) 902-4203 (international) and asking to join the Amyris, Inc. call.

About Amyris

Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market^TM technology platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit http://www.amyris.com. 

Amyris, the Amyris logo, Biossance, Costa Brazil, JVN, Lab-to-Market, Pipette, and Rose Inc. are trademarks or registered trademarks of Amyris, Inc. or its subsidiaries in the U.S. and/or other countries.

View original content to download multimedia:https://www.prnewswire.com/news-releases/amyris-to-host-third-quarter-2022-financial-results-conference-call-on-november-8-301663987.html

SOURCE Amyris, Inc.

FAQ

When will Amyris report its Q3 2022 financial results?

Amyris will report its Q3 2022 financial results on November 8, 2022, after market close.

What time is the Amyris Q3 2022 conference call?

The conference call for Amyris Q3 2022 results will be held at 1:30 PM Pacific Time on November 8, 2022.

Who will speak during the Amyris Q3 2022 conference call?

CEO John Melo and CFO Han Kieftenbeld will speak during the Amyris Q3 2022 conference call.

How can I access the Amyris Q3 2022 conference call?

You can access the Amyris Q3 2022 conference call via phone or through a live webcast on the company's Investor Relations website.

What is Amyris's business focus?

Amyris focuses on sustainable ingredients for Clean Health & Beauty and Flavors & Fragrances using its Lab-to-Market technology platform.